A conditionally immortal clonal stem cell line from human cortical neuroepithelium for the treatment of ischemic stroke

Experimental Neurology

Volumn 199, Issue 1, 2006, Pages 143-155

  Pollock, Kenneth ^a   Stroemer, Paul ^a   Patel, Sara ^a   Stevanato, Lara ^a   Hope, Andrew ^a   Miljan, Erik ^a   Dong, Ziping ^a   Hodges, Helen ^a,b   Price, Jack ^b   Sinden, John D ^a  

^a RENEURON LTD   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

4 Hydroxy tamoxifen; c mycERTAM; Cortex; Immortalization; MCAo; Stable; Stem cell; Stroke; Transplantation

Indexed keywords

4 HYDROXYTAMOXIFEN; GROWTH FACTOR; HYBRID PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN CORTEX; BRAIN ISCHEMIA; CELL CYCLE ARREST; CELL DIFFERENTIATION; CELL GROWTH; CELL IMMORTALIZATION; CELL LINE; CELL MIGRATION; CELL PROLIFERATION; CELL STIMULATION; CELL TRANSPLANTATION; CLONE; CONTROLLED STUDY; DNA MODIFICATION; FETUS; HUMAN; HUMAN CELL; HUMAN TISSUE; KARYOTYPE 46,XY; LONG TERM CARE; MALE; NERVE CELL; NERVE CELL CULTURE; NEURAL STEM CELL; NEUROEPITHELIUM; NONHUMAN; PRIORITY JOURNAL; RAT; SENSORIMOTOR FUNCTION; SOMATIC CELL; STATISTICAL SIGNIFICANCE; STEM CELL TRANSPLANTATION; STROKE; SURVIVAL RATE; SURVIVAL TIME; THERAPY EFFECT; TRANSGENE;

ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; CELL DIFFERENTIATION; CELL MOVEMENT; CEREBRAL CORTEX; CLONE CELLS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FETUS; HUMANS; HYDROXYTESTOSTERONES; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; MOTOR ACTIVITY; NEUROEPITHELIAL CELLS; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STEM CELL TRANSPLANTATION; STEM CELLS; TELOMERASE; TIME FACTORS; TRANSDUCTION, GENETIC;

EID: 33745206856     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2005.12.011     Document Type: Article

References (44)

1. Adams H., Adams R., Del Zoppo G., and Goldstein L.B. Guidelines for the early management of patients with ischemic stroke-2005 guidelines update. A scientific statement from the stroke council of the American Heart Association/American Stroke Association. Stroke 36 (2005) 916-923
2. Borlongan C.V., Tajima Y., Trojanowski J.Q., Lee M.-Y., and Sanberg P.R. Transplantation of cryopreserved human embryonal carcinoma-derived neurons (NT2N cells) promotes functional recovery in ischemic rats. Exp. Neurol. 149 (1998) 310-321
3. Caldwell M.A., He X., Wilkie N., Pollack S., Marshall G., Wafford K.A., and Svendson C. Growth factors regulate the survival and fate of cells derived from human neurospheres. Nat. Biotechnol. 19 (2001) 475-479
4. Carpenter M.K., Cui X., Hu Z.Y., Jackson J., Sherman S., Seiger A., and Wahlberg L.U. In vitro expansion of a multipotent population of human neural progenitor cells. Exp. Neurol. 158 (1999) 265-278
5. Cerni C. Telomeres, telomerase, and myc. An update. Mutat. Res. 462 (2000) 31-47
6. Chen J., Sanberg P., Li Y., Wang L., Lu M., Willing A., Sanchez-Ramos J., and Chopp M. Intravenous administration of human umbilical cord blood reduces behavioural deficits after stroke in rats. Stroke 32 (2001) 2682-2688
7. Chen J., Li Y., Zhang Z., Lu D., Lu M., and Chopp M. Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke 32 (2001) 1005-1011
8. Chu K., Kim M., Park K., Jeong S., Park H., Jung K., Lee S., Kang L., Lee K., Park D., Kim S., and Roh J. Human neural stem cells improve sensorimotor deficits in the adult rat brain with experimental focal ischemia. Brain Res. 1016 (2004) 145-153
9. Cosset F.L., Takeuchi Y., Battini J.L., Weiss R.A., and Collins M.K.L. High titer packaging cells producing recombinant retroviruses resistant to human serum. J. Virol. 69 (1995) 7430-7436
10. Dunnett S., Isacson O., Sirinathsinghji D., Clarke D., and Bjorklund A. Striatal grafts in rats with unilateral neostriatal lesions: III. Recovery from dopamine-dependent motor asymmetry and deficits in skilled paw reaching. Neuroscience 24 (1988) 813-820
11. Flax J.D., Aurora S., Yang C.H., Simonin C., Wills A.M., Billinghurst L.L., Jendoubi M., Sidman R.L., Wolfe J.H., Kim S.U., and Snyder E.Y. Engraftable human neural stem cells respond to developmental cues and express foreign genes. Nat. Biotechnol. 16 (1998) 1033-1039
12. Freeman T.B., Cicchetti F., Hauser R.A., Deacon T.W., Li X.J., Hersch S.M., Nauert G.M., Sanberg P.R., Kordower J.H., Saporta S., and Isacson O. Transplanted fetal striatum in Huntington's disease: phenotypic development and lack of pathology. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 13877-13882
13. Gilman S. Time course and outcome of recovery from stroke: relevance to stem cell treatment. Exp. Neurol. 199 1 (2006) 37-41
14. Gladstone D., Black S., and Hakim A. Toward wisdom from failure; lessons from neuroprotective stroke trials and new therapeutic directions. Stroke 33 (2002) 2123-2136
15. Gray J.A., Hodges H., and Sinden J. Prospects for the clinical application of neural transplantation with the use of conditionally immortalized neuroepithelial stem cells. Philos. Trans. R. Soc. London, Ser. B Biol. Sci. 354 (1999) 1407-1421
16. Hantraye P., Riche D., Maziere M., and Isacson O. Intratstriatal transplantation of cross-species fetal striatal cells reduces abnormal movements in a primate model of Huntington disease. Proc. Natl. Acad. Sci. U. S. A. 89 (1992) 4187-4191
17. Hernandez T.D., and Schallert T. Seizures and recovery from experimental brain damage. Exp. Neurol. 102 (1988) 318-324
18. Imitola J., Raddassi K., Park K.I., Mueller F.-J., Nieto M., Frenkel D., Li J., Sidman R.L., Walsh C.A., Snyder E.Y., and Khoury S.J. Directed migration of human and mouse neural stem cells to site of CNS injury by the SDF1α/CXCR4-dependent pathway. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 18117-18122
19. Kelly S., Bliss T.M., Shah A.K., Sun G.H., Ma M., Foo W.C., Masel J., Yenari M.A., Weissman I.L., Uchida N., Palmer T., and Steinberg G.K. Transplanted human fetal neural stem cells survive, migrate, and differentiate in ischaemic rat cerebral cortex. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 11839-11844
20. Kim J.-H., Auerbach J.M., Rodriguez-Gomez J.A., Velasco I., Gavin D., Lumelsky N., Lee S.-H., Nguyen J., Sanchez-Pernaute R., Bankiewicz K., and McKay R. Dopamine neurons derived from embryonic stem cells in an animal model of Parkinson's disease. Nature 418 (2002) 50-56
21. Kondziolka D., Wechsler L., Goldstein S., Meltzer C., Thulborn K.R., Gebel J., Jannetta P., DeCesare S., Elder E.M., McGrogan M., Reitman M.A., and Bynum L. Transplantation of cultured human neuronal cells for patients with stroke. Neurology 55 (2000) 565-569
22. Kwakkel G., Kollen B., van der Grond J., and Prevo A. Probability of regaining dexterity in the flaccid upper limb, impact of severity of paresis and time since onset in acute stroke. Stroke 34 (2003) 2181-2186
23. Lendahl U., Zimmerman L.B., and McKay R.D. CNS stem cells express a new class of intermediate filament protein. Cell. 60 (1990) 585-595
24. Levenbook I.S., Petricciani J.C., Qi Y., Elisberg B.L., Rogers J.L., Jackson L.B., Wierenga D.E., and Webster B.A. Tumourigenicity testing of primate cell lines in nude mice, muscle organ culture and for colony formation in soft agarose. J. Biol. Stand. 13 (1985) 135-141
25. Littlewood T.D., Hancock D.C., Danielian P.S., Parker M.G., and Evan G.I. A modified oestrogen receptor-ligand binding domain as an improved switch for the regulation of heterologous proteins. Nucleic Acids Res. 23 (1995) 1686-1690
26. Markgraf C.G., Green E.J., Hurwitz B.E., Morikawa E., Dietrich W.D., McCabe P.M., Ginsbeg M.D., and Schneiderman N. Sensorimotor and cognitive consequences of middle cerebral artery occlusion in rats. Brain Res. 575 (1992) 238-246
27. Modo M., Stroemer R.P., Tang E., Veizovic T., Sowinski P., and Hodges H. Neurological sequelae and long-term behavioural assessment of rats with transient middle cerebral artery occlusion. J. Neurosci. Methods 104 (2000) 99-109
28. Modo M., Stroemer R.P., Tang E., Patel S., and Hodges H. Effects of implantation site of stem cell grafts on behavioural recovery from stroke damage. Stroke 33 (2002) 2270-2278
29. Newman S., Misiuta I., Willing A.E., Zigova T., Karl R.C., Borlongan C.V., and Sanberg P.R. Tumorigenicity issues of embryonic carcinoma-derived stem cells: relevance to surgical trials using NT2 and hNT neural cells. Stem Cells Dev. 14 (2005) 29-43
30. Olanow C.W., Goetz C.G., Kordower J.H., Stoessl A.J., Sossi V., Brin M.F., Shannon K.M., Nauert G.M., Perl D.P., Godbold J., and Freeman T.B. A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease. Ann. Neurol. 54 (2003) 403-414
31. Ourednik V., and Ourednik J. Multifaceted dialogue between graft and host in neurotransplantation. J. Neurosci. Res. 76 (2004) 193-204
32. Ourednik J., Ourednik V., Lynch W.P., Schachner M., and Snyder E.Y. Neural stem cells display an inherent mechanism for rescuing dysfunctional neurons. Nature Biotech 20 (2002) 1103-1110
33. Park K.I., Hack M.A., Ourednik J., Yandava B., Flax J.D., Stieg P.E., Gullans S., Jensen F.E., Sidman R.L., Ourednik V., and Snyder E.Y. Acute injury directs the migration, proliferation, and the differentiation of solid organ stem cells: evidence from the effect of hypoxia-ischemia in the CNS on clonal "reporter" neural stem cells. Exp. Neurol. 199 1 (2006) 156-178
34. Peschanski M., Bachoud-Levi A.C., and Hantraye P. Integrating fetal neural transplants into a therapeutic strategy: the example of Huntington's disease. Brain 127 (2004) 1219-1228
35. Saito I., Segawa H., Shinokawa Y., Taniguchi M., and Tsutsumi K. Middle cerebral artery occlusion: correlation of computed tomography with clinical outcome. Stroke 18 (1987) 863-868
36. Saporta S., Borlongan C., and Sanberg P. Neural transplantation of human neuroteratocarcinoma (hNR) neurons into ischemic rats. A quantitative dose-response analysis of cell survival and behavioural recovery. Neuroscience 91 (1999) 519-525
37. Sinden J.D., Rashid Doubell F., Kershaw T.R., Nelson A., Chadwick A., Jat P.S., Noble M.D., Hodges H., and Gray J.A. Recovery of spatial learning by grafts of a conditionally immortalized hippocampal neuroepithelial cell line into the ischaemia-lesioned hippocampus. Neuroscience 81 (1997) 599-608
38. Takagi Y., Takahashi J., Saiki H., Morizane A., Hayashi T., Kishi Y., Fukuda H., Okamoto Y., Koyanagi M., Ideguchi M., Hayashi H., Imazato T., Kawasaki H., Suemori H., Omachi S., Iida H., Itoh N., Nakatsuji N., Sasai Y., and Hashimoto N. Dopaminergic neurons generated from monkey embryonic stem cells function in a Parkinson primate model. J. Clin. Invest. 115 (2005) 102-109
39. Tohyama T., Lee T., Rorke L., Marvin M., McKay R., and Trojanowski J. Nestin expression in embryonic human neuroepithelium and in human neuroepithelial tumor cells. Lab. Invest. 66 (1992) 303-313
40. Veizovic T., Beech J., Stroemer R.P., Watson W., and Hodges H. Resolution of stroke deficits following contralateral grafts of conditionally immortal neuroepithelial stem cells. Stroke 39 (2001) 842-851
41. Vendrame M., Cassady J., Newcomb J., Butler T., Pennypacker K., Zigova Y., Davis Sanberg C., Sanberg P., and Willing A. Infusion of human umbilical cord blood cells in a rat model of stroke dose-dependently rescues behavioural deficits and reduces infarct volume. Stroke 35 (2004) 2390-2395
42. Vescovi A.L., Parati E.A., Gritti A., Poulin P., Ferrario M., Wanke E., Frolichsthal-Schoeller P., Cova L., Arcellana-Panlilio M., Colombo A., and Galli R. Isolation and cloning of multipotential stem cells from the embryonic human CNS and establishment of transplantable human neural stem cell lines by epigenetic stimulation. Exp. Neurol. 156 (1999) 71-83
43. Willing A., Vendrame M., Mallery J., Cassady C.J., Davis S., Sanchez-Ramos J., and Sanberg P. Mobilized peripheral blood cells administered intravenously produce functional recovery in stroke. Cell Transplant. 12 (2003) 449-454
44. Zea Longa Z., Weinstein P., Carlson S., and Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20 (1989) 84-91